Loading...
Market
Will Suven Pharma's market cap exceed Rs 10,000 crore by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
BSE market capitalization data
Story
Suven Pharma Hits All-Time High of Rs 1,245 After US FDA Closes Inspection
Sep 9, 2024, 04:45 AM
Suven Pharma's Hyderabad-based manufacturing facility, operated by its subsidiary Casper Pharma, received an Establishment Inspection Report (EIR) from the US FDA. The inspection, conducted between July 8-12, 2024, was categorized as Voluntary Action Indicated (VAI) and has been deemed closed. Following this disclosure, Suven Pharma's share price surged by up to 3.67%, reaching an all-time high of Rs 1,245 per share on the BSE.
View original story
Similar markets
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
More than $10 billion • 25%
Below $2 billion • 25%
$2 billion to $4 billion • 25%
$4 billion to $6 billion • 25%
Above $6 billion • 25%
Yes • 50%
No • 50%
Top 5 • 25%
Rank 6-10 • 25%
Rank 11-15 • 25%
Below 15 • 25%
Below $1 billion • 25%
$1 billion to $2 billion • 25%
$2 billion to $3 billion • 25%
Above $3 billion • 25%
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
